nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—ABCB1—peripheral nervous system neoplasm	0.34	1	CbGaD
Boceprevir—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0541	0.165	CbGbCtD
Boceprevir—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0378	0.115	CbGbCtD
Boceprevir—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0378	0.115	CbGbCtD
Boceprevir—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0262	0.08	CbGbCtD
Boceprevir—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0248	0.0757	CbGbCtD
Boceprevir—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0227	0.0693	CbGbCtD
Boceprevir—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0227	0.0691	CbGbCtD
Boceprevir—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0211	0.0643	CbGbCtD
Boceprevir—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0162	0.0493	CbGbCtD
Boceprevir—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0151	0.0459	CbGbCtD
Boceprevir—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0148	0.0451	CbGbCtD
Boceprevir—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0101	0.0308	CbGbCtD
Boceprevir—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00968	0.0295	CbGbCtD
Boceprevir—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00887	0.027	CbGbCtD
Boceprevir—CTSK—skull—peripheral nervous system neoplasm	0.00722	0.252	CbGeAlD
Boceprevir—CTSK—forelimb—peripheral nervous system neoplasm	0.00695	0.243	CbGeAlD
Boceprevir—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00605	0.0184	CbGbCtD
Boceprevir—CTSK—Osteoclast Signaling—IFNB1—peripheral nervous system neoplasm	0.00299	0.101	CbGpPWpGaD
Boceprevir—CMA1—ACE Inhibitor Pathway—KNG1—peripheral nervous system neoplasm	0.00296	0.0999	CbGpPWpGaD
Boceprevir—Telaprevir—ABCB1—peripheral nervous system neoplasm	0.00262	1	CrCbGaD
Boceprevir—CTSL—trigeminal ganglion—peripheral nervous system neoplasm	0.00245	0.0855	CbGeAlD
Boceprevir—CTSL—parotid gland—peripheral nervous system neoplasm	0.00231	0.0806	CbGeAlD
Boceprevir—CTSK—trigeminal ganglion—peripheral nervous system neoplasm	0.00185	0.0644	CbGeAlD
Boceprevir—CTSK—parotid gland—peripheral nervous system neoplasm	0.00174	0.0608	CbGeAlD
Boceprevir—CTSS—trigeminal ganglion—peripheral nervous system neoplasm	0.00162	0.0564	CbGeAlD
Boceprevir—CTSS—parotid gland—peripheral nervous system neoplasm	0.00153	0.0532	CbGeAlD
Boceprevir—CTSL—cerebellum—peripheral nervous system neoplasm	0.00107	0.0373	CbGeAlD
Boceprevir—CMA1—Peptide hormone metabolism—BCHE—peripheral nervous system neoplasm	0.000931	0.0314	CbGpPWpGaD
Boceprevir—CTSK—cerebellum—peripheral nervous system neoplasm	0.000805	0.0281	CbGeAlD
Boceprevir—CTSS—cerebellum—peripheral nervous system neoplasm	0.000706	0.0246	CbGeAlD
Boceprevir—CYP3A5—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000632	0.0213	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—NCAM1—peripheral nervous system neoplasm	0.000488	0.0165	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—NCAM1—peripheral nervous system neoplasm	0.000488	0.0165	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—NCAM1—peripheral nervous system neoplasm	0.000454	0.0153	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—CD55—peripheral nervous system neoplasm	0.000405	0.0137	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—CD55—peripheral nervous system neoplasm	0.000405	0.0137	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—NCAM1—peripheral nervous system neoplasm	0.000404	0.0136	CbGpPWpGaD
Boceprevir—CTSV—Degradation of the extracellular matrix—CASP3—peripheral nervous system neoplasm	0.000369	0.0125	CbGpPWpGaD
Boceprevir—CTSL—Degradation of the extracellular matrix—CASP3—peripheral nervous system neoplasm	0.000369	0.0125	CbGpPWpGaD
Boceprevir—CTSV—Toll-Like Receptors Cascades—PTPN11—peripheral nervous system neoplasm	0.000356	0.012	CbGpPWpGaD
Boceprevir—CTSL—Toll-Like Receptors Cascades—PTPN11—peripheral nervous system neoplasm	0.000356	0.012	CbGpPWpGaD
Boceprevir—CYP3A4—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000346	0.0117	CbGpPWpGaD
Boceprevir—CMA1—Degradation of the extracellular matrix—CASP3—peripheral nervous system neoplasm	0.000343	0.0116	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—CD55—peripheral nervous system neoplasm	0.000336	0.0113	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—NCAM1—peripheral nervous system neoplasm	0.000333	0.0112	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—PTPN11—peripheral nervous system neoplasm	0.000331	0.0112	CbGpPWpGaD
Boceprevir—CTSK—Degradation of the extracellular matrix—CASP3—peripheral nervous system neoplasm	0.000306	0.0103	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—PPP3R1—peripheral nervous system neoplasm	0.000296	0.00997	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—PPP3R1—peripheral nervous system neoplasm	0.000296	0.00997	CbGpPWpGaD
Boceprevir—CTSK—Toll-Like Receptors Cascades—PTPN11—peripheral nervous system neoplasm	0.000295	0.00996	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—CD34—peripheral nervous system neoplasm	0.000295	0.00995	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—CD34—peripheral nervous system neoplasm	0.000295	0.00995	CbGpPWpGaD
Boceprevir—CYP3A4—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000294	0.00991	CbGpPWpGaD
Boceprevir—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	0.000285	0.00996	CbGeAlD
Boceprevir—CTSS—Innate Immune System—CD55—peripheral nervous system neoplasm	0.000276	0.00933	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—ERBB2—peripheral nervous system neoplasm	0.000262	0.00883	CbGpPWpGaD
Boceprevir—CTSV—Endochondral Ossification—AKT1—peripheral nervous system neoplasm	0.00026	0.00878	CbGpPWpGaD
Boceprevir—CTSS—Degradation of the extracellular matrix—CASP3—peripheral nervous system neoplasm	0.000252	0.0085	CbGpPWpGaD
Boceprevir—CYP3A5—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000246	0.00828	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—PPP3R1—peripheral nervous system neoplasm	0.000245	0.00826	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—CD34—peripheral nervous system neoplasm	0.000244	0.00824	CbGpPWpGaD
Boceprevir—CTSK—RANKL/RANK Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000244	0.00821	CbGpPWpGaD
Boceprevir—CTSS—Toll-Like Receptors Cascades—PTPN11—peripheral nervous system neoplasm	0.000243	0.0082	CbGpPWpGaD
Boceprevir—CTSL—Primary Focal Segmental Glomerulosclerosis FSGS—AKT1—peripheral nervous system neoplasm	0.000237	0.00799	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CD55—peripheral nervous system neoplasm	0.000236	0.00796	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CD55—peripheral nervous system neoplasm	0.000236	0.00796	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—IFNB1—peripheral nervous system neoplasm	0.000205	0.00691	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—IFNB1—peripheral nervous system neoplasm	0.000205	0.00691	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—PPP3R1—peripheral nervous system neoplasm	0.000202	0.0068	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—CD34—peripheral nervous system neoplasm	0.000201	0.00679	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—NRAS—peripheral nervous system neoplasm	0.000199	0.00672	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CD55—peripheral nervous system neoplasm	0.000196	0.0066	CbGpPWpGaD
Boceprevir—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000189	0.00639	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CD34—peripheral nervous system neoplasm	0.000179	0.00603	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CD34—peripheral nervous system neoplasm	0.000179	0.00603	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	0.000176	0.00593	CbGpPWpGaD
Boceprevir—CTSV—Immune System—PPP3R1—peripheral nervous system neoplasm	0.000172	0.00581	CbGpPWpGaD
Boceprevir—CTSL—Immune System—PPP3R1—peripheral nervous system neoplasm	0.000172	0.00581	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—IFNB1—peripheral nervous system neoplasm	0.00017	0.00573	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CD55—peripheral nervous system neoplasm	0.000161	0.00543	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—CASP3—peripheral nervous system neoplasm	0.000155	0.00522	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—CASP3—peripheral nervous system neoplasm	0.000155	0.00522	CbGpPWpGaD
Boceprevir—CTSV—Immune System—NCAM1—peripheral nervous system neoplasm	0.000152	0.00513	CbGpPWpGaD
Boceprevir—CTSL—Immune System—NCAM1—peripheral nervous system neoplasm	0.000152	0.00513	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CD34—peripheral nervous system neoplasm	0.000148	0.005	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000148	0.00499	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—HRAS—peripheral nervous system neoplasm	0.000146	0.00491	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—CASP3—peripheral nervous system neoplasm	0.000144	0.00485	CbGpPWpGaD
Boceprevir—CTSK—Immune System—PPP3R1—peripheral nervous system neoplasm	0.000143	0.00481	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000142	0.00478	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—IFNB1—peripheral nervous system neoplasm	0.00014	0.00472	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	0.000132	0.00444	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—AKT1—peripheral nervous system neoplasm	0.000129	0.00434	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—CASP3—peripheral nervous system neoplasm	0.000128	0.00432	CbGpPWpGaD
Boceprevir—CTSK—Immune System—NCAM1—peripheral nervous system neoplasm	0.000126	0.00425	CbGpPWpGaD
Boceprevir—ABCB1—cerebellum—peripheral nervous system neoplasm	0.000124	0.00434	CbGeAlD
Boceprevir—CTSS—Immune System—CD34—peripheral nervous system neoplasm	0.000122	0.00412	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IFNB1—peripheral nervous system neoplasm	0.000119	0.00403	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IFNB1—peripheral nervous system neoplasm	0.000119	0.00403	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PPP3R1—peripheral nervous system neoplasm	0.000117	0.00396	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—PTPN11—peripheral nervous system neoplasm	0.000115	0.00389	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—PTPN11—peripheral nervous system neoplasm	0.000115	0.00389	CbGpPWpGaD
Boceprevir—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000114	0.00385	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000112	0.00378	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—PTPN11—peripheral nervous system neoplasm	0.000111	0.00374	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—PTPN11—peripheral nervous system neoplasm	0.000111	0.00374	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.00011	0.00372	CbGpPWpGaD
Boceprevir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000109	0.00367	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—CASP3—peripheral nervous system neoplasm	0.000106	0.00356	CbGpPWpGaD
Boceprevir—CTSS—Immune System—NCAM1—peripheral nervous system neoplasm	0.000104	0.0035	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000103	0.00349	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IFNB1—peripheral nervous system neoplasm	9.89e-05	0.00334	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—PTPN11—peripheral nervous system neoplasm	9.56e-05	0.00323	CbGpPWpGaD
Boceprevir—CTSV—Immune System—HGF—peripheral nervous system neoplasm	9.21e-05	0.00311	CbGpPWpGaD
Boceprevir—CTSL—Immune System—HGF—peripheral nervous system neoplasm	9.21e-05	0.00311	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—PTPN11—peripheral nervous system neoplasm	9.18e-05	0.0031	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—ERBB2—peripheral nervous system neoplasm	9.12e-05	0.00308	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—ERBB2—peripheral nervous system neoplasm	9.12e-05	0.00308	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—ERBB2—peripheral nervous system neoplasm	8.76e-05	0.00295	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—ERBB2—peripheral nervous system neoplasm	8.76e-05	0.00295	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IFNB1—peripheral nervous system neoplasm	8.14e-05	0.00275	CbGpPWpGaD
Boceprevir—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	7.97e-05	0.000294	CcSEcCtD
Boceprevir—Influenza—Doxorubicin—peripheral nervous system neoplasm	7.92e-05	0.000292	CcSEcCtD
Boceprevir—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	7.92e-05	0.000292	CcSEcCtD
Boceprevir—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	7.91e-05	0.000291	CcSEcCtD
Boceprevir—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	7.9e-05	0.000291	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—PTPN11—peripheral nervous system neoplasm	7.87e-05	0.00266	CbGpPWpGaD
Boceprevir—Pruritus—Alitretinoin—peripheral nervous system neoplasm	7.87e-05	0.00029	CcSEcCtD
Boceprevir—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	7.84e-05	0.000289	CcSEcCtD
Boceprevir—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	7.81e-05	0.000288	CcSEcCtD
Boceprevir—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	7.81e-05	0.000288	CcSEcCtD
Boceprevir—Paraesthesia—Etoposide—peripheral nervous system neoplasm	7.8e-05	0.000287	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	7.77e-05	0.00262	CbGpPWpGaD
Boceprevir—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	7.76e-05	0.000286	CcSEcCtD
Boceprevir—Weight decreased—Epirubicin—peripheral nervous system neoplasm	7.74e-05	0.000285	CcSEcCtD
Boceprevir—Dyspnoea—Etoposide—peripheral nervous system neoplasm	7.74e-05	0.000285	CcSEcCtD
Boceprevir—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	7.72e-05	0.000284	CcSEcCtD
Boceprevir—Asthenia—Vincristine—peripheral nervous system neoplasm	7.69e-05	0.000283	CcSEcCtD
Boceprevir—Pneumonia—Epirubicin—peripheral nervous system neoplasm	7.67e-05	0.000283	CcSEcCtD
Boceprevir—CTSK—Immune System—HGF—peripheral nervous system neoplasm	7.63e-05	0.00258	CbGpPWpGaD
Boceprevir—Infestation—Epirubicin—peripheral nervous system neoplasm	7.63e-05	0.000281	CcSEcCtD
Boceprevir—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	7.63e-05	0.000281	CcSEcCtD
Boceprevir—Vomiting—Dactinomycin—peripheral nervous system neoplasm	7.63e-05	0.000281	CcSEcCtD
Boceprevir—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	7.62e-05	0.000281	CcSEcCtD
Boceprevir—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	7.61e-05	0.00028	CcSEcCtD
Boceprevir—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	7.57e-05	0.000279	CcSEcCtD
Boceprevir—Rash—Dactinomycin—peripheral nervous system neoplasm	7.56e-05	0.000279	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—PTPN11—peripheral nervous system neoplasm	7.56e-05	0.00255	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—ERBB2—peripheral nervous system neoplasm	7.56e-05	0.00255	CbGpPWpGaD
Boceprevir—Decreased appetite—Etoposide—peripheral nervous system neoplasm	7.55e-05	0.000278	CcSEcCtD
Boceprevir—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	7.52e-05	0.000277	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	7.5e-05	0.000276	CcSEcCtD
Boceprevir—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	7.49e-05	0.000276	CcSEcCtD
Boceprevir—Fatigue—Etoposide—peripheral nervous system neoplasm	7.49e-05	0.000276	CcSEcCtD
Boceprevir—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	7.48e-05	0.000276	CcSEcCtD
Boceprevir—Stomatitis—Epirubicin—peripheral nervous system neoplasm	7.44e-05	0.000274	CcSEcCtD
Boceprevir—Pain—Etoposide—peripheral nervous system neoplasm	7.42e-05	0.000274	CcSEcCtD
Boceprevir—Constipation—Etoposide—peripheral nervous system neoplasm	7.42e-05	0.000274	CcSEcCtD
Boceprevir—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	7.42e-05	0.000273	CcSEcCtD
Boceprevir—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	7.42e-05	0.000273	CcSEcCtD
Boceprevir—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	7.4e-05	0.000273	CcSEcCtD
Boceprevir—Dysuria—Doxorubicin—peripheral nervous system neoplasm	7.4e-05	0.000273	CcSEcCtD
Boceprevir—Dizziness—Alitretinoin—peripheral nervous system neoplasm	7.36e-05	0.000271	CcSEcCtD
Boceprevir—Diarrhoea—Vincristine—peripheral nervous system neoplasm	7.33e-05	0.00027	CcSEcCtD
Boceprevir—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	7.32e-05	0.000269	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—ERBB2—peripheral nervous system neoplasm	7.26e-05	0.00245	CbGpPWpGaD
Boceprevir—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	7.23e-05	0.000266	CcSEcCtD
Boceprevir—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	7.22e-05	0.000266	CcSEcCtD
Boceprevir—Epistaxis—Epirubicin—peripheral nervous system neoplasm	7.2e-05	0.000265	CcSEcCtD
Boceprevir—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	7.16e-05	0.000264	CcSEcCtD
Boceprevir—Sinusitis—Epirubicin—peripheral nervous system neoplasm	7.16e-05	0.000264	CcSEcCtD
Boceprevir—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	7.15e-05	0.000264	CcSEcCtD
Boceprevir—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	7.14e-05	0.000263	CcSEcCtD
Boceprevir—Nausea—Dactinomycin—peripheral nervous system neoplasm	7.13e-05	0.000262	CcSEcCtD
Boceprevir—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	7.12e-05	0.000262	CcSEcCtD
Boceprevir—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	7.1e-05	0.000262	CcSEcCtD
Boceprevir—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	7.1e-05	0.000262	CcSEcCtD
Boceprevir—Dizziness—Vincristine—peripheral nervous system neoplasm	7.09e-05	0.000261	CcSEcCtD
Boceprevir—Vomiting—Alitretinoin—peripheral nervous system neoplasm	7.07e-05	0.000261	CcSEcCtD
Boceprevir—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	7.06e-05	0.00026	CcSEcCtD
Boceprevir—Infestation—Doxorubicin—peripheral nervous system neoplasm	7.06e-05	0.00026	CcSEcCtD
Boceprevir—Rash—Alitretinoin—peripheral nervous system neoplasm	7.01e-05	0.000258	CcSEcCtD
Boceprevir—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	7.01e-05	0.000258	CcSEcCtD
Boceprevir—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	7e-05	0.000258	CcSEcCtD
Boceprevir—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	6.98e-05	0.000257	CcSEcCtD
Boceprevir—Headache—Alitretinoin—peripheral nervous system neoplasm	6.97e-05	0.000257	CcSEcCtD
Boceprevir—CTSL—Innate Immune System—NRAS—peripheral nervous system neoplasm	6.94e-05	0.00234	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—NRAS—peripheral nervous system neoplasm	6.94e-05	0.00234	CbGpPWpGaD
Boceprevir—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	6.92e-05	0.000255	CcSEcCtD
Boceprevir—Urticaria—Etoposide—peripheral nervous system neoplasm	6.9e-05	0.000254	CcSEcCtD
Boceprevir—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	6.88e-05	0.000254	CcSEcCtD
Boceprevir—Rhinitis—Epirubicin—peripheral nervous system neoplasm	6.87e-05	0.000253	CcSEcCtD
Boceprevir—Abdominal pain—Etoposide—peripheral nervous system neoplasm	6.86e-05	0.000253	CcSEcCtD
Boceprevir—Body temperature increased—Etoposide—peripheral nervous system neoplasm	6.86e-05	0.000253	CcSEcCtD
Boceprevir—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	6.86e-05	0.000253	CcSEcCtD
Boceprevir—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	6.86e-05	0.000253	CcSEcCtD
Boceprevir—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	6.82e-05	0.000251	CcSEcCtD
Boceprevir—Vomiting—Vincristine—peripheral nervous system neoplasm	6.81e-05	0.000251	CcSEcCtD
Boceprevir—Asthenia—Cisplatin—peripheral nervous system neoplasm	6.8e-05	0.00025	CcSEcCtD
Boceprevir—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	6.8e-05	0.00025	CcSEcCtD
Boceprevir—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	6.76e-05	0.000249	CcSEcCtD
Boceprevir—Rash—Vincristine—peripheral nervous system neoplasm	6.76e-05	0.000249	CcSEcCtD
Boceprevir—Dermatitis—Vincristine—peripheral nervous system neoplasm	6.75e-05	0.000249	CcSEcCtD
Boceprevir—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	6.75e-05	0.000249	CcSEcCtD
Boceprevir—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	6.73e-05	0.000248	CcSEcCtD
Boceprevir—CTSL—Immune System—PTPN11—peripheral nervous system neoplasm	6.72e-05	0.00227	CbGpPWpGaD
Boceprevir—CTSV—Immune System—PTPN11—peripheral nervous system neoplasm	6.72e-05	0.00227	CbGpPWpGaD
Boceprevir—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	6.71e-05	0.000247	CcSEcCtD
Boceprevir—Headache—Vincristine—peripheral nervous system neoplasm	6.71e-05	0.000247	CcSEcCtD
Boceprevir—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	6.68e-05	0.000246	CcSEcCtD
Boceprevir—CTSV—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	6.66e-05	0.00225	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	6.66e-05	0.00225	CbGpPWpGaD
Boceprevir—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	6.66e-05	0.000245	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	6.65e-05	0.00224	CbGpPWpGaD
Boceprevir—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	6.62e-05	0.000244	CcSEcCtD
Boceprevir—Nausea—Alitretinoin—peripheral nervous system neoplasm	6.61e-05	0.000243	CcSEcCtD
Boceprevir—Visual impairment—Epirubicin—peripheral nervous system neoplasm	6.6e-05	0.000243	CcSEcCtD
Boceprevir—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	6.59e-05	0.000243	CcSEcCtD
Boceprevir—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	6.48e-05	0.000239	CcSEcCtD
Boceprevir—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	6.48e-05	0.000239	CcSEcCtD
Boceprevir—Eye disorder—Epirubicin—peripheral nervous system neoplasm	6.4e-05	0.000236	CcSEcCtD
Boceprevir—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	6.4e-05	0.000236	CcSEcCtD
Boceprevir—Tinnitus—Epirubicin—peripheral nervous system neoplasm	6.39e-05	0.000235	CcSEcCtD
Boceprevir—Nausea—Vincristine—peripheral nervous system neoplasm	6.37e-05	0.000235	CcSEcCtD
Boceprevir—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	6.36e-05	0.000234	CcSEcCtD
Boceprevir—Flushing—Epirubicin—peripheral nervous system neoplasm	6.36e-05	0.000234	CcSEcCtD
Boceprevir—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	6.35e-05	0.000234	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	6.34e-05	0.00214	CbGpPWpGaD
Boceprevir—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	6.31e-05	0.000232	CcSEcCtD
Boceprevir—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	6.29e-05	0.000232	CcSEcCtD
Boceprevir—CTSS—Immune System—HGF—peripheral nervous system neoplasm	6.29e-05	0.00212	CbGpPWpGaD
Boceprevir—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	6.26e-05	0.000231	CcSEcCtD
Boceprevir—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	6.24e-05	0.00023	CcSEcCtD
Boceprevir—Asthenia—Etoposide—peripheral nervous system neoplasm	6.23e-05	0.000229	CcSEcCtD
Boceprevir—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	6.23e-05	0.000229	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—ERBB2—peripheral nervous system neoplasm	6.22e-05	0.0021	CbGpPWpGaD
Boceprevir—Angiopathy—Epirubicin—peripheral nervous system neoplasm	6.21e-05	0.000229	CcSEcCtD
Boceprevir—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	6.21e-05	0.000229	CcSEcCtD
Boceprevir—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	6.19e-05	0.000228	CcSEcCtD
Boceprevir—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	6.17e-05	0.000227	CcSEcCtD
Boceprevir—Chills—Epirubicin—peripheral nervous system neoplasm	6.15e-05	0.000226	CcSEcCtD
Boceprevir—Pruritus—Etoposide—peripheral nervous system neoplasm	6.14e-05	0.000226	CcSEcCtD
Boceprevir—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	6.12e-05	0.000225	CcSEcCtD
Boceprevir—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	6.11e-05	0.000225	CcSEcCtD
Boceprevir—Alopecia—Epirubicin—peripheral nervous system neoplasm	6.05e-05	0.000223	CcSEcCtD
Boceprevir—Vomiting—Cisplatin—peripheral nervous system neoplasm	6.03e-05	0.000222	CcSEcCtD
Boceprevir—Mental disorder—Epirubicin—peripheral nervous system neoplasm	6e-05	0.000221	CcSEcCtD
Boceprevir—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	5.99e-05	0.000221	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—ERBB2—peripheral nervous system neoplasm	5.98e-05	0.00202	CbGpPWpGaD
Boceprevir—Rash—Cisplatin—peripheral nervous system neoplasm	5.98e-05	0.00022	CcSEcCtD
Boceprevir—Dermatitis—Cisplatin—peripheral nervous system neoplasm	5.97e-05	0.00022	CcSEcCtD
Boceprevir—Malnutrition—Epirubicin—peripheral nervous system neoplasm	5.96e-05	0.00022	CcSEcCtD
Boceprevir—Erythema—Epirubicin—peripheral nervous system neoplasm	5.96e-05	0.00022	CcSEcCtD
Boceprevir—Diarrhoea—Etoposide—peripheral nervous system neoplasm	5.94e-05	0.000219	CcSEcCtD
Boceprevir—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	5.92e-05	0.000218	CcSEcCtD
Boceprevir—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	5.91e-05	0.000218	CcSEcCtD
Boceprevir—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	5.88e-05	0.000217	CcSEcCtD
Boceprevir—Flushing—Doxorubicin—peripheral nervous system neoplasm	5.88e-05	0.000217	CcSEcCtD
Boceprevir—Flatulence—Epirubicin—peripheral nervous system neoplasm	5.88e-05	0.000216	CcSEcCtD
Boceprevir—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	5.84e-05	0.000215	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	5.81e-05	0.00196	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.81e-05	0.00196	CbGpPWpGaD
Boceprevir—Back pain—Epirubicin—peripheral nervous system neoplasm	5.77e-05	0.000212	CcSEcCtD
Boceprevir—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	5.75e-05	0.000212	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—NRAS—peripheral nervous system neoplasm	5.75e-05	0.00194	CbGpPWpGaD
Boceprevir—Dizziness—Etoposide—peripheral nervous system neoplasm	5.74e-05	0.000211	CcSEcCtD
Boceprevir—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	5.73e-05	0.000211	CcSEcCtD
Boceprevir—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	5.72e-05	0.000211	CcSEcCtD
Boceprevir—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	5.71e-05	0.00021	CcSEcCtD
Boceprevir—Chills—Doxorubicin—peripheral nervous system neoplasm	5.69e-05	0.00021	CcSEcCtD
Boceprevir—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	5.66e-05	0.000209	CcSEcCtD
Boceprevir—Nausea—Cisplatin—peripheral nervous system neoplasm	5.63e-05	0.000207	CcSEcCtD
Boceprevir—Vision blurred—Epirubicin—peripheral nervous system neoplasm	5.62e-05	0.000207	CcSEcCtD
Boceprevir—Alopecia—Doxorubicin—peripheral nervous system neoplasm	5.6e-05	0.000206	CcSEcCtD
Boceprevir—CTSK—Immune System—PTPN11—peripheral nervous system neoplasm	5.57e-05	0.00188	CbGpPWpGaD
Boceprevir—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	5.55e-05	0.000205	CcSEcCtD
Boceprevir—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	5.53e-05	0.000204	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	5.52e-05	0.00186	CbGpPWpGaD
Boceprevir—Vomiting—Etoposide—peripheral nervous system neoplasm	5.52e-05	0.000203	CcSEcCtD
Boceprevir—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	5.52e-05	0.000203	CcSEcCtD
Boceprevir—Erythema—Doxorubicin—peripheral nervous system neoplasm	5.52e-05	0.000203	CcSEcCtD
Boceprevir—Anaemia—Epirubicin—peripheral nervous system neoplasm	5.51e-05	0.000203	CcSEcCtD
Boceprevir—Agitation—Epirubicin—peripheral nervous system neoplasm	5.48e-05	0.000202	CcSEcCtD
Boceprevir—Rash—Etoposide—peripheral nervous system neoplasm	5.47e-05	0.000202	CcSEcCtD
Boceprevir—Dermatitis—Etoposide—peripheral nervous system neoplasm	5.47e-05	0.000201	CcSEcCtD
Boceprevir—Headache—Etoposide—peripheral nervous system neoplasm	5.44e-05	0.0002	CcSEcCtD
Boceprevir—Flatulence—Doxorubicin—peripheral nervous system neoplasm	5.44e-05	0.0002	CcSEcCtD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	5.41e-05	0.00182	CbGpPWpGaD
Boceprevir—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	5.4e-05	0.000199	CcSEcCtD
Boceprevir—Malaise—Epirubicin—peripheral nervous system neoplasm	5.38e-05	0.000198	CcSEcCtD
Boceprevir—Vertigo—Epirubicin—peripheral nervous system neoplasm	5.36e-05	0.000197	CcSEcCtD
Boceprevir—Syncope—Epirubicin—peripheral nervous system neoplasm	5.35e-05	0.000197	CcSEcCtD
Boceprevir—Leukopenia—Epirubicin—peripheral nervous system neoplasm	5.34e-05	0.000197	CcSEcCtD
Boceprevir—Back pain—Doxorubicin—peripheral nervous system neoplasm	5.34e-05	0.000197	CcSEcCtD
Boceprevir—CTSL—Immune System—ERBB2—peripheral nervous system neoplasm	5.31e-05	0.00179	CbGpPWpGaD
Boceprevir—CTSV—Immune System—ERBB2—peripheral nervous system neoplasm	5.31e-05	0.00179	CbGpPWpGaD
Boceprevir—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	5.3e-05	0.000195	CcSEcCtD
Boceprevir—Palpitations—Epirubicin—peripheral nervous system neoplasm	5.27e-05	0.000194	CcSEcCtD
Boceprevir—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	5.24e-05	0.000193	CcSEcCtD
Boceprevir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	5.23e-05	0.00176	CbGpPWpGaD
Boceprevir—Cough—Epirubicin—peripheral nervous system neoplasm	5.2e-05	0.000192	CcSEcCtD
Boceprevir—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	5.2e-05	0.000192	CcSEcCtD
Boceprevir—Nausea—Etoposide—peripheral nervous system neoplasm	5.16e-05	0.00019	CcSEcCtD
Boceprevir—Hypertension—Epirubicin—peripheral nervous system neoplasm	5.15e-05	0.00019	CcSEcCtD
Boceprevir—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	5.12e-05	0.000189	CcSEcCtD
Boceprevir—Anaemia—Doxorubicin—peripheral nervous system neoplasm	5.1e-05	0.000188	CcSEcCtD
Boceprevir—Arthralgia—Epirubicin—peripheral nervous system neoplasm	5.08e-05	0.000187	CcSEcCtD
Boceprevir—Chest pain—Epirubicin—peripheral nervous system neoplasm	5.08e-05	0.000187	CcSEcCtD
Boceprevir—Myalgia—Epirubicin—peripheral nervous system neoplasm	5.08e-05	0.000187	CcSEcCtD
Boceprevir—CTSV—Innate Immune System—HRAS—peripheral nervous system neoplasm	5.08e-05	0.00171	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—HRAS—peripheral nervous system neoplasm	5.08e-05	0.00171	CbGpPWpGaD
Boceprevir—Agitation—Doxorubicin—peripheral nervous system neoplasm	5.07e-05	0.000187	CcSEcCtD
Boceprevir—Anxiety—Epirubicin—peripheral nervous system neoplasm	5.06e-05	0.000186	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	5.04e-05	0.000186	CcSEcCtD
Boceprevir—Discomfort—Epirubicin—peripheral nervous system neoplasm	5.02e-05	0.000185	CcSEcCtD
Boceprevir—Malaise—Doxorubicin—peripheral nervous system neoplasm	4.98e-05	0.000183	CcSEcCtD
Boceprevir—Dry mouth—Epirubicin—peripheral nervous system neoplasm	4.97e-05	0.000183	CcSEcCtD
Boceprevir—Vertigo—Doxorubicin—peripheral nervous system neoplasm	4.96e-05	0.000183	CcSEcCtD
Boceprevir—Syncope—Doxorubicin—peripheral nervous system neoplasm	4.95e-05	0.000182	CcSEcCtD
Boceprevir—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	4.94e-05	0.000182	CcSEcCtD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	4.93e-05	0.00166	CbGpPWpGaD
Boceprevir—Confusional state—Epirubicin—peripheral nervous system neoplasm	4.91e-05	0.000181	CcSEcCtD
Boceprevir—Palpitations—Doxorubicin—peripheral nervous system neoplasm	4.88e-05	0.00018	CcSEcCtD
Boceprevir—CTSV—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	4.87e-05	0.00164	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	4.87e-05	0.00164	CbGpPWpGaD
Boceprevir—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	4.85e-05	0.000179	CcSEcCtD
Boceprevir—Infection—Epirubicin—peripheral nervous system neoplasm	4.83e-05	0.000178	CcSEcCtD
Boceprevir—Cough—Doxorubicin—peripheral nervous system neoplasm	4.81e-05	0.000177	CcSEcCtD
Boceprevir—Shock—Epirubicin—peripheral nervous system neoplasm	4.79e-05	0.000176	CcSEcCtD
Boceprevir—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	4.77e-05	0.000176	CcSEcCtD
Boceprevir—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	4.76e-05	0.000176	CcSEcCtD
Boceprevir—Hypertension—Doxorubicin—peripheral nervous system neoplasm	4.76e-05	0.000175	CcSEcCtD
Boceprevir—Tachycardia—Epirubicin—peripheral nervous system neoplasm	4.75e-05	0.000175	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—NRAS—peripheral nervous system neoplasm	4.73e-05	0.0016	CbGpPWpGaD
Boceprevir—Skin disorder—Epirubicin—peripheral nervous system neoplasm	4.73e-05	0.000174	CcSEcCtD
Boceprevir—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	4.7e-05	0.000173	CcSEcCtD
Boceprevir—Chest pain—Doxorubicin—peripheral nervous system neoplasm	4.7e-05	0.000173	CcSEcCtD
Boceprevir—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	4.7e-05	0.000173	CcSEcCtD
Boceprevir—Myalgia—Doxorubicin—peripheral nervous system neoplasm	4.7e-05	0.000173	CcSEcCtD
Boceprevir—Anxiety—Doxorubicin—peripheral nervous system neoplasm	4.68e-05	0.000172	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	4.67e-05	0.000172	CcSEcCtD
Boceprevir—Discomfort—Doxorubicin—peripheral nervous system neoplasm	4.64e-05	0.000171	CcSEcCtD
Boceprevir—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	4.59e-05	0.000169	CcSEcCtD
Boceprevir—CTSS—Immune System—PTPN11—peripheral nervous system neoplasm	4.59e-05	0.00155	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	4.57e-05	0.00154	CbGpPWpGaD
Boceprevir—Hypotension—Epirubicin—peripheral nervous system neoplasm	4.55e-05	0.000168	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	4.55e-05	0.00153	CbGpPWpGaD
Boceprevir—Confusional state—Doxorubicin—peripheral nervous system neoplasm	4.54e-05	0.000167	CcSEcCtD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	4.51e-05	0.00152	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—AKT1—peripheral nervous system neoplasm	4.48e-05	0.00151	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—AKT1—peripheral nervous system neoplasm	4.48e-05	0.00151	CbGpPWpGaD
Boceprevir—Infection—Doxorubicin—peripheral nervous system neoplasm	4.47e-05	0.000165	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	4.43e-05	0.000163	CcSEcCtD
Boceprevir—Shock—Doxorubicin—peripheral nervous system neoplasm	4.43e-05	0.000163	CcSEcCtD
Boceprevir—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	4.42e-05	0.000163	CcSEcCtD
Boceprevir—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	4.41e-05	0.000162	CcSEcCtD
Boceprevir—CTSK—Immune System—ERBB2—peripheral nervous system neoplasm	4.4e-05	0.00148	CbGpPWpGaD
Boceprevir—Insomnia—Epirubicin—peripheral nervous system neoplasm	4.4e-05	0.000162	CcSEcCtD
Boceprevir—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	4.39e-05	0.000162	CcSEcCtD
Boceprevir—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.38e-05	0.00148	CbGpPWpGaD
Boceprevir—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	4.37e-05	0.000161	CcSEcCtD
Boceprevir—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	4.37e-05	0.000161	CcSEcCtD
Boceprevir—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	4.35e-05	0.00016	CcSEcCtD
Boceprevir—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	4.34e-05	0.00016	CcSEcCtD
Boceprevir—CTSL—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	4.3e-05	0.00145	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	4.3e-05	0.00145	CbGpPWpGaD
Boceprevir—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	4.28e-05	0.000158	CcSEcCtD
Boceprevir—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	4.23e-05	0.000156	CcSEcCtD
Boceprevir—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	4.22e-05	0.00142	CbGpPWpGaD
Boceprevir—Hypotension—Doxorubicin—peripheral nervous system neoplasm	4.21e-05	0.000155	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—HRAS—peripheral nervous system neoplasm	4.21e-05	0.00142	CbGpPWpGaD
Boceprevir—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	4.2e-05	0.000155	CcSEcCtD
Boceprevir—Fatigue—Epirubicin—peripheral nervous system neoplasm	4.2e-05	0.000155	CcSEcCtD
Boceprevir—Constipation—Epirubicin—peripheral nervous system neoplasm	4.16e-05	0.000153	CcSEcCtD
Boceprevir—Pain—Epirubicin—peripheral nervous system neoplasm	4.16e-05	0.000153	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	4.1e-05	0.000151	CcSEcCtD
Boceprevir—Insomnia—Doxorubicin—peripheral nervous system neoplasm	4.07e-05	0.00015	CcSEcCtD
Boceprevir—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	4.04e-05	0.000149	CcSEcCtD
Boceprevir—CTSL—Immune System—NRAS—peripheral nervous system neoplasm	4.04e-05	0.00136	CbGpPWpGaD
Boceprevir—CTSV—Immune System—NRAS—peripheral nervous system neoplasm	4.04e-05	0.00136	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4.04e-05	0.00136	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	4.04e-05	0.00136	CbGpPWpGaD
Boceprevir—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	4.01e-05	0.000148	CcSEcCtD
Boceprevir—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	4.01e-05	0.000148	CcSEcCtD
Boceprevir—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	3.98e-05	0.000147	CcSEcCtD
Boceprevir—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	3.96e-05	0.000146	CcSEcCtD
Boceprevir—CYP3A5—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.92e-05	0.00132	CbGpPWpGaD
Boceprevir—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	3.91e-05	0.000144	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	3.89e-05	0.000143	CcSEcCtD
Boceprevir—Fatigue—Doxorubicin—peripheral nervous system neoplasm	3.88e-05	0.000143	CcSEcCtD
Boceprevir—Urticaria—Epirubicin—peripheral nervous system neoplasm	3.87e-05	0.000142	CcSEcCtD
Boceprevir—Constipation—Doxorubicin—peripheral nervous system neoplasm	3.85e-05	0.000142	CcSEcCtD
Boceprevir—Pain—Doxorubicin—peripheral nervous system neoplasm	3.85e-05	0.000142	CcSEcCtD
Boceprevir—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	3.85e-05	0.000142	CcSEcCtD
Boceprevir—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	3.85e-05	0.000142	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—AKT1—peripheral nervous system neoplasm	3.71e-05	0.00125	CbGpPWpGaD
Boceprevir—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	3.71e-05	0.000137	CcSEcCtD
Boceprevir—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	3.68e-05	0.000136	CcSEcCtD
Boceprevir—CTSS—Immune System—ERBB2—peripheral nervous system neoplasm	3.62e-05	0.00122	CbGpPWpGaD
Boceprevir—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	3.59e-05	0.000132	CcSEcCtD
Boceprevir—Urticaria—Doxorubicin—peripheral nervous system neoplasm	3.58e-05	0.000132	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	3.57e-05	0.0012	CbGpPWpGaD
Boceprevir—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	3.56e-05	0.000131	CcSEcCtD
Boceprevir—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	3.56e-05	0.000131	CcSEcCtD
Boceprevir—Asthenia—Epirubicin—peripheral nervous system neoplasm	3.49e-05	0.000129	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—HRAS—peripheral nervous system neoplasm	3.46e-05	0.00117	CbGpPWpGaD
Boceprevir—Pruritus—Epirubicin—peripheral nervous system neoplasm	3.44e-05	0.000127	CcSEcCtD
Boceprevir—CTSK—Immune System—NRAS—peripheral nervous system neoplasm	3.35e-05	0.00113	CbGpPWpGaD
Boceprevir—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	3.33e-05	0.000123	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	3.33e-05	0.00112	CbGpPWpGaD
Boceprevir—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	3.32e-05	0.000122	CcSEcCtD
Boceprevir—Asthenia—Doxorubicin—peripheral nervous system neoplasm	3.23e-05	0.000119	CcSEcCtD
Boceprevir—Dizziness—Epirubicin—peripheral nervous system neoplasm	3.22e-05	0.000119	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.19e-05	0.00108	CbGpPWpGaD
Boceprevir—Pruritus—Doxorubicin—peripheral nervous system neoplasm	3.19e-05	0.000117	CcSEcCtD
Boceprevir—Vomiting—Epirubicin—peripheral nervous system neoplasm	3.09e-05	0.000114	CcSEcCtD
Boceprevir—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	3.08e-05	0.000114	CcSEcCtD
Boceprevir—Rash—Epirubicin—peripheral nervous system neoplasm	3.07e-05	0.000113	CcSEcCtD
Boceprevir—Dermatitis—Epirubicin—peripheral nervous system neoplasm	3.07e-05	0.000113	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—AKT1—peripheral nervous system neoplasm	3.06e-05	0.00103	CbGpPWpGaD
Boceprevir—Headache—Epirubicin—peripheral nervous system neoplasm	3.05e-05	0.000112	CcSEcCtD
Boceprevir—Dizziness—Doxorubicin—peripheral nervous system neoplasm	2.98e-05	0.00011	CcSEcCtD
Boceprevir—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.96e-05	0.000999	CbGpPWpGaD
Boceprevir—CTSV—Immune System—HRAS—peripheral nervous system neoplasm	2.96e-05	0.000997	CbGpPWpGaD
Boceprevir—CTSL—Immune System—HRAS—peripheral nervous system neoplasm	2.96e-05	0.000997	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	2.94e-05	0.000991	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.9e-05	0.000978	CbGpPWpGaD
Boceprevir—Nausea—Epirubicin—peripheral nervous system neoplasm	2.89e-05	0.000106	CcSEcCtD
Boceprevir—Vomiting—Doxorubicin—peripheral nervous system neoplasm	2.86e-05	0.000105	CcSEcCtD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	2.86e-05	0.000964	CbGpPWpGaD
Boceprevir—Rash—Doxorubicin—peripheral nervous system neoplasm	2.84e-05	0.000105	CcSEcCtD
Boceprevir—CYP3A5—Metabolism—GNS—peripheral nervous system neoplasm	2.84e-05	0.000957	CbGpPWpGaD
Boceprevir—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	2.84e-05	0.000104	CcSEcCtD
Boceprevir—Headache—Doxorubicin—peripheral nervous system neoplasm	2.82e-05	0.000104	CcSEcCtD
Boceprevir—CTSS—Immune System—NRAS—peripheral nervous system neoplasm	2.76e-05	0.00093	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—NME1—peripheral nervous system neoplasm	2.72e-05	0.000917	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.7e-05	0.000911	CbGpPWpGaD
Boceprevir—Nausea—Doxorubicin—peripheral nervous system neoplasm	2.67e-05	9.85e-05	CcSEcCtD
Boceprevir—CYP3A5—Metabolism—COX2—peripheral nervous system neoplasm	2.62e-05	0.000883	CbGpPWpGaD
Boceprevir—CTSV—Immune System—AKT1—peripheral nervous system neoplasm	2.61e-05	0.000881	CbGpPWpGaD
Boceprevir—CTSL—Immune System—AKT1—peripheral nervous system neoplasm	2.61e-05	0.000881	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	2.48e-05	0.000838	CbGpPWpGaD
Boceprevir—CTSK—Immune System—HRAS—peripheral nervous system neoplasm	2.45e-05	0.000826	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.43e-05	0.000819	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.26e-05	0.000763	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	2.25e-05	0.000761	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.23e-05	0.000753	CbGpPWpGaD
Boceprevir—CTSK—Immune System—AKT1—peripheral nervous system neoplasm	2.16e-05	0.00073	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	2.14e-05	0.000722	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	2.05e-05	0.000692	CbGpPWpGaD
Boceprevir—CTSS—Immune System—HRAS—peripheral nervous system neoplasm	2.02e-05	0.000681	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	1.98e-05	0.000666	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.86e-05	0.000627	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.82e-05	0.000615	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.8e-05	0.000606	CbGpPWpGaD
Boceprevir—CTSS—Immune System—AKT1—peripheral nervous system neoplasm	1.78e-05	0.000601	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.78e-05	0.000599	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	1.76e-05	0.000594	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ENO2—peripheral nervous system neoplasm	1.72e-05	0.00058	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.57e-05	0.000529	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—BCHE—peripheral nervous system neoplasm	1.45e-05	0.00049	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	1.45e-05	0.000488	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.39e-05	0.000467	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—TH—peripheral nervous system neoplasm	1.37e-05	0.000461	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	1.32e-05	0.000445	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	1.3e-05	0.000437	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	1.26e-05	0.000426	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.22e-05	0.000412	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	1.22e-05	0.000411	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GNAS—peripheral nervous system neoplasm	1.11e-05	0.000376	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	1.1e-05	0.00037	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ABCB1—peripheral nervous system neoplasm	1.09e-05	0.000369	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.05e-05	0.000353	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	1.03e-05	0.000348	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	8.41e-06	0.000284	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	7.99e-06	0.00027	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	6.75e-06	0.000228	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.44e-06	0.000217	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	6.35e-06	0.000214	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	5.18e-06	0.000175	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	5.09e-06	0.000172	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	3.01e-06	0.000101	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	2.27e-06	7.66e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	1.4e-06	4.72e-05	CbGpPWpGaD
